A sensitive and high-throughput assay to detect low-abundance proteins in serum
- 12 March 2006
- journal article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 12 (4), 473-477
- https://doi.org/10.1038/nm1378
Abstract
The ability to detect antigens immunologically is limited by the affinity of the antibodies and the amount of antigens. We have now succeeded in creating a modular, facile amplification system, termed fluorescent amplification catalyzed by T7 polymerase technique (FACTT). Such a system can detect protein targets specifically at subfemtomolar levels ( approximately 0.08 fM). We describe here the detection of Her2 (also known as Neu) from rodent and human sera. FACTT is adaptable to high-throughput screening and automation and provides a practical method to enhance current ELISAs in medical practice.Keywords
This publication has 26 references indexed in Scilit:
- Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of ProteinsScience, 2003
- Characterization and utilization of two novel anti-erbB-2 monoclonal antibodies in detection of soluble ErbB-2 for breast cancer prognosisCancer Letters, 2003
- Multiplexed protein profiling on microarrays by rolling-circle amplificationNature Biotechnology, 2002
- Kinetic modeling and simulation of in vitro transcription by phage T7 RNA polymeraseBiotechnology & Bioengineering, 2001
- Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivoNature Biotechnology, 2000
- neu(c-erbB-2/HER2) and the Epidermal Growth Factor Receptor (EGFR) in Breast CancerPathobiology, 1993
- Enzyme immunoassay techniques an overviewJournal of Immunological Methods, 1992
- Expression of c-erbB-2 in Human Pancreatic AdenocarcinomasPathobiology, 1991
- Neil (c-erbB-2), a Tumor Marker in Carcinoma of the Female BreastPathobiology, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989